Skip to main content

13-12-2019 | Breast cancer | Video

SABCS 2019 | ctDNA may predict early-stage TNBC recurrence

Milan Radovich shares data suggesting a role for circulating tumour DNA in identifying triple-negative breast cancer patients likely to experience relapse after surgery (2:26).

Funding for independent interviews at SABCS 2019 was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.

See the research in context now

with trial summaries, expert opinion and congress coverage

Image Credits